New #EU4Health call for #tenders on #mentalhealth training & exchange programmes
The call supports the @EU_Commission 's comprehensive approach to mental health through capacity-building & trainings for health professionals
💶€9M
📌4/9
🐦🔗: https://n.respublicae.eu/EU_HaDEA/status/1668199260607721473
📢 The highlights of our Management Board meeting are now available & include updates on:
✅approval of cancer medicines with potential to transform patient care
✅ recent initiatives on clinical trials in the EU
👉https://www.ema.europa.eu/en/news/ema-management-board-highlights-june-2023-meeting
#cancer #ClinicalTrials #patients
🐦🔗: https://n.respublicae.eu/EMA_News/status/1667151495219888130
Today we're discussing priorities for #EU4Health incl.
▶️Improving & fostering health
▶️Protecting people
▶️Enhancing access to medicinal products & medical devices
▶️Preparing health systems for the digital era
▶️Synergies & complementarities
#HealthUnion
https://europa.eu/!jHjdvJ
🐦🔗: https://n.respublicae.eu/EU_Health/status/1667067258655453184
The 2024 2-stage #HorizonEU Health calls are still open for applications!
Check out available funding for research on access to innovative, sustainable and high-quality #healthcare for people in vulnerable situations
📌Deadline: 19 September
https://hadea.ec.europa.eu/news/4-two-stage-calls-are-open-applications-under-horizon-europe-health-2023-03-31_en
🐦🔗: https://n.respublicae.eu/EU_HaDEA/status/1667143275306790914
✅Crisis preparedness & response
✅The #EUCancerPlan
✅An #EUPharmaStrategy for Europe
✅A comprehensive approach to #MentalHealth
This is our #HealthUnion, protecting health together
🔗https://europa.eu/!7Kb3BR
🐦🔗: https://n.respublicae.eu/EU_Health/status/1667107607436304384
Today, we've published a report to support the understanding and work on health promotion and disease prevention, contributing to national health system performance assessment frameworks.
Read more & register for the #EUHPP launch event: https://europa.eu/!VHFmdM
#HealthUnion
🐦🔗: https://n.respublicae.eu/EU_Health/status/1667124887347949570
At its June meeting, EMA's #safety committee, the #PRAC, carried out its work to assess all aspects of risk management related to the use of #medicines.
More information in our meeting highlights: https://www.ema.europa.eu/en/news/meeting-highlights-pharmacovigilance-risk-assessment-committee-prac-5-8-june-2023
🐦🔗: https://n.respublicae.eu/EMA_News/status/1667127819984306176
The 2nd wave of the 2023 #EU4Health calls for action grants will open soon!
Save the date for the upcoming info session to present the policy context, objectives, expected impact and procedure
📌30 June 2023
https://hadea.ec.europa.eu/events/info-day-eu4health-2023-open-calls-action-grants-2023-06-30_en
🐦🔗: https://n.respublicae.eu/EU_HaDEA/status/1667077904553967620
Just published!
A new scientific paper 📰on #clinicaltrial designs and statistical approaches applied in COVID-19 vaccine efficacy trials is now available.
It focuses on the first 4⃣ approved #COVID19vaccines.
Click to read the full paper 👇
https://doi.org/10.1080/19466315.2023.2211538.
🐦🔗: https://n.respublicae.eu/EMA_News/status/1666798759320211456
Today’s fast changing world impacts #MentalHealth
With 2⃣0⃣ flagship initiatives & EUR 1.23 billion, we're helping EU countries:
▶️Make mental health a priority
▶️Support those needing help
▶️Protect children & the vulnerable
Read more: https://europa.eu/!XCqGfQ
#HealthUnion
🐦🔗: https://n.respublicae.eu/EU_Health/status/1666380240589840384
#MentalHealth is another building block of a strong 🇪🇺 #HealthUnion that makes health a priority for all.
Many people still find it difficult to speak up and seek the help and answers they need.
Together, we must break this stigma.
🙌There is no health without mental health!
🐦🔗: https://n.respublicae.eu/SKyriakidesEU/status/1666395671472099328
RT @ECDC_EU: #JustPublished!
A joint #ECDC - @EMA_News statement on updating #COVID19 vaccines composition for new #SARSCoV2 virus variants.
Read full here:
https://www.ecdc.europa.eu/en/news-events/ecdc-ema-statement-updating-covid-19-vaccines-composition-new-sars-cov-2-virus-variants https://t.co/8EDIYlBk97
🐦🔗: https://n.respublicae.eu/EMA_News/status/1666389827669950476
RT @ECDC_EU: In line with the outcome of recent meetings of international regulators and the @WHO, @EMA_News Emergency Task Force recommends updating vaccines to target #XBB strains (a subgroup of #Omicron), which have become dominant in Europe and other parts of the world. https://t.co/gas97lAmW6
🐦🔗: https://n.respublicae.eu/EMA_News/status/1666389806585184257
RT @ECDC_EU: Both agencies (@ECDC_EU & @EMA_News) note that monovalent vaccines (vaccines targeting only one strain such as XBB.1.5) are a reasonable choice to provide protection against current dominant and emerging strains.
#COVID19 https://t.co/7szyGfVoiZ
🐦🔗: https://n.respublicae.eu/EMA_News/status/1666389773240377346
Follow live as we present a new European comprehensive approach to #mentalhealth with @MargSchinas and Commissioner @SKyriakidesEU
https://europa.eu/!XCqGfQ
#HealthUnion https://n.respublicae.eu/i/broadcasts/1MnGnpQmOmmxO
🐦🔗: https://n.respublicae.eu/EU_Health/status/1666381064602886151
Have you been affected by the shortage of the medicine Visudyne ❓ #Myopia
Participate in our #survey and help us improve our communication!
The aim is to collect information on how patients were informed about the recent medicine #shortages.
📩 Send your feedback by 9 June
🐦🔗: https://n.respublicae.eu/EMA_News/status/1666331656641454080
EMA and the EU network will keep monitoring the #safety of #COVID19vaccines and therapeutics, as we do for all authorised medicines in the 🇪🇺. #EMAPresser
🐦🔗: https://n.respublicae.eu/EMA_News/status/1666080323002839046
The available data confirm that the #COVID19vaccines are safe and add to the evidence from the clinical trials.
Most of the side effects of the vaccines are mild and short-lived. Serious side effects are very rare.
🐦🔗: https://n.respublicae.eu/EMA_News/status/1666080218505940996
If an unusual pattern emerged, the #PRAC performed an in-depth analysis of the reports to quickly identify potential safety issues with #Covid19vaccines.
The 🇪🇺 pharmacovigilance system showed that it can detect and manage emerging #safety issues quickly.
🐦🔗: https://n.respublicae.eu/EMA_News/status/1666080058241581057
We have encouraged people who received the #Covid19vaccine and healthcare professionals to report suspected side effects.
Out of nearly 1 billion vaccines administered, Eudravigilance received more than 1.7 million reports in the EU.
🐦🔗: https://n.respublicae.eu/EMA_News/status/1666079807732580361
Unofficial automated mirror. No copyright asserted. ∎ Latest news from the European Medicines Agency, the European Union agency responsible for the evaluation and supervision of medicines. RTs ≠ endorsement.